S-1: SCWorx Files S-1 for Resale, Faces Delisting Risk

SCWorx Corp. filed an S-1 registration statement for the resale of up to 53.2 million common shares by selling stockholders, while grappling with recurring losses, negative cash flow, and a Nasdaq delisting threat.

Summary

• SCWorx Corp. filed an S-1 registration statement for the resale of up to 53,220,845 shares of common stock by existing selling stockholders.
• The company will not receive any proceeds from the sale of common stock by the selling stockholders, but may receive up to $16,500,000 if warrants are exercised for cash.
• SCWorx is a provider of data content and services for healthcare providers, focusing on data normalization, interoperability, and big data analytics through a Software-as-a-Service (SaaS) model.
• The company has a history of losses and negative operating cash flows, with a net loss of $3,694,927 for the nine months ended September 30, 2025, and $1,136,225 for the year ended December 31, 2024.
• Revenue declined approximately 21% to $2,989,599 in 2024 from $3,804,943 in 2023, and further decreased to $2,108,730 for the nine months ended September 30, 2025, from $2,313,850 in the same period of 2024.
• As of September 30, 2025, the company had $684,000 in cash on hand and used $1,414,534 in cash from operations during the nine months ended September 30, 2025.
• SCWorx received a Nasdaq Notice of Deficiency on April 10, 2025, for not meeting the $1.00 minimum bid price requirement and was granted an extension until April 6, 2026, to regain compliance.
• The company's Certificate of Incorporation was amended on December 10, 2025, to increase the authorized shares to 155,000,000.
• As of January 6, 2026, there were 15,826,834 shares of Common Stock outstanding, 39,810 shares of Series A Convertible Preferred Stock outstanding, and 54,049,156 outstanding and exercisable warrants with a weighted-average exercise price of $0.31.

Sentiment

Score: 2

Explanation: The overall sentiment is highly negative due to recurring and increasing losses, declining revenue, significant going concern doubt, and the imminent threat of Nasdaq delisting. While the filing addresses registration obligations, the underlying financial health and operational challenges are severe.

Positives

• The company has fulfilled its registration obligations under various agreements by filing this S-1, which may facilitate the liquidity for selling stockholders.
• Potential proceeds of up to $16,500,000 could be received by the company if all warrants are exercised for cash, which would be used for working capital and general corporate purposes.
• Stockholder approvals were obtained on December 8, 2025, for the September Warrants, indicating continued investor support for certain capital activities.

Negatives

• The company has a history of recurring losses and negative operating cash flows, with a net loss of $3,694,927 for the nine months ended September 30, 2025, and an accumulated deficit of $34,670,993 as of that date.
• Revenue has been declining, falling 21% in 2024 compared to 2023, and further decreasing in the first nine months of 2025 compared to the prior year period.
• There is substantial doubt about the company's ability to continue as a going concern, as stated by its auditors.
• The company received a Nasdaq Notice of Deficiency for failing to meet the minimum bid price requirement and faces delisting if compliance is not regained by April 6, 2026.
• Future capital raises are subject to anti-dilution provisions and require consent from existing investors, potentially limiting financing options.
• The issuance of a large number of shares for resale (53,220,845) and potential warrant exercises could cause significant dilution and adversely impact the stock price.

Risks

• The issuance of common stock to investors will cause significant dilution, and the sale of these shares could cause the stock price to fall.
• Future sales and issuances of common stock or other securities might result in significant dilution and could cause the price of common stock to decline.
• The company has a history of losses and negative cash flows, which are expected to continue, raising substantial doubt about its ability to continue as a going concern.
• If the company is unable to grow its revenue, it is unlikely to achieve or sustain profitability.
• The company may need additional capital, and if unable to obtain it on acceptable terms, it will not be able to implement its business strategy, and existing stockholders may face dilution.
• Failure to regain and maintain compliance with Nasdaq's minimum bid price rule by April 6, 2026, will result in delisting, materially affecting the company's stock price and ability to raise capital.
• The company's common stock price has fluctuated substantially and is likely to continue to be volatile, which could result in losses to investors and potential litigation.
• The sale or availability for sale of substantial amounts of common stock could adversely affect the market price.
• Any defects or errors in the company's services, or failures to meet customer expectations, could result in large damage claims.
• The company derives a significant portion of its revenue from a few customers, and the loss of one or a reduction in demand could adversely affect its business.
• Many customer contracts allow termination without cause, which could impair the business.
• Failure to adequately expand the direct sales force will impede growth.
• Inability to attract and retain qualified executive officers, managers, and consultants could hinder efficient operation.
• The industry is highly competitive, and failure to compete effectively could reduce contracts and market share.
• Customers are subject to consolidation and rapid technological/regulatory change, and the company's inability to adjust could reduce demand.
• Economic downturns could cause decreased expenditures in the industries served, adversely affecting the business.
• Operating results may fluctuate due to factors difficult to forecast and outside the company's control.
• Actual results could differ from estimates and assumptions used to prepare financial statements.
• Tax filings are subject to audit, which could result in additional tax liability and penalties.
• A failure to establish and maintain effective internal control over financial reporting could have a material adverse effect on business and operating results.
• Complying with laws and regulations affecting public companies will increase costs and demands on management.
• Failure to manage planned growth effectively, including potential acquisitions, could harm revenue and operating results.
• The value of goodwill and other intangible assets may decline, potentially leading to delisting if stockholder equity requirements are not met.
• Any future acquisitions may result in dilutive equity issuances, increased indebtedness, and amortization expense.
• The company may become involved in litigation, which could incur substantial expenses.
• Dependence on subcontractors and suppliers could increase costs and impair contract completion.
• Insurance coverage may be inadequate to cover all significant risk exposures.
• The company may be required to pay for the defense of clients, officers, or directors in accordance with indemnification provisions.
• Inability to establish, protect, or enforce intellectual property rights adequately could negatively affect the business.
• Changes in laws, regulations, and other requirements could adversely affect the business.
• Disruptions in information technology systems or security breaches could have an adverse impact on operations.

Future Outlook

The company expects to continue incurring losses and negative operating cash flows for the foreseeable future. It plans to expand its sales force, product offerings, and project capabilities, and may consider acquisitions, all of which require additional capital. The ability to continue as a going concern is uncertain, and the company is monitoring its common stock trading price to regain Nasdaq compliance, with a reverse stock split being a potential future action if needed.

Management Comments

• "We believe that these conditions raise substantial doubt about our ability to continue as a going concern."
• "We intend to use any proceeds that we receive from the Selling Stockholders through the exercise of warrants to purchase Common Stock for working capital and general corporate purposes."
• "We plan to expand our account management/sales force, subject to receipt of additional funding."
• "The Company is monitoring its Common Stock trading price. If compliance with the minimum bid price requirement is not regained within the extended 180-day period, the Company will implement a reverse stock split within the range previously approved by its shareholders."

Industry Context

SCWorx operates in the highly competitive healthcare information technology sector, providing data management solutions to hospitals and health systems. The industry is characterized by rapid technological and regulatory changes, as well as consolidation among customers. The company's focus on data normalization, interoperability, and big data analytics aligns with ongoing trends in healthcare to improve efficiency and reduce costs, but its financial struggles highlight the challenges of securing and retaining contracts in this environment.

Comparison to Industry Standards

• The company's recurring losses and negative cash flows are significantly below industry standards for healthy, growing SaaS companies in the healthcare IT sector, which typically aim for profitability and positive cash flow to sustain operations and investment.
• The Nasdaq minimum bid price deficiency and the risk of delisting indicate a failure to meet basic listing standards, which is a critical underperformance compared to publicly traded peers.
• The declining revenue trend (21% decrease in 2024, further decline in 9M 2025) contrasts sharply with the growth expectations for many innovative healthcare IT solutions providers, suggesting a struggle to capture market share or retain existing business effectively.
• The substantial doubt about the company's ability to continue as a going concern is a severe deviation from the financial stability expected of established public companies and indicates a high level of financial distress not typically seen in successful industry players.

Management Changes

Corporate Governance

Legal Proceedings

• The company may be involved in lawsuits and regulatory actions, including class action lawsuits, in the ordinary course of business, seeking compensation for alleged personal injury, workers compensation, violations of labor laws, employment discrimination, breach of contract, property damage, punitive damages, civil penalties, and other losses or injunctive relief.
• The ultimate resolution of any such matters could have a material adverse effect on financial condition, results of operations, and cash flows, and could result in substantial costs and diversion of management attention.

Related Party Transactions

• The description of certain relationships and related transactions and director independence is incorporated by reference from Part III, Item 13 of the Company's Annual Report on Form 10-K as filed with the SEC on March 31, 2025. No new specific related party transactions are detailed in this S-1.

Stakeholder Impact

• **Shareholders**: Face significant dilution risk from the resale of 53.2 million shares and potential future capital raises. The Nasdaq delisting threat poses a material adverse effect on share price and liquidity. Recurring losses and going concern doubt threaten the value of their investment.
• **Employees/Service Providers**: The 2025 Equity Incentive Plan aims to recruit and retain talent by offering equity participation, aligning their interests with the company's growth. However, the company's financial instability and potential delisting could impact employee morale and retention.
• **Customers**: The company's financial struggles and potential inability to secure additional capital could impact its ability to develop new products and maintain service quality, potentially affecting customer satisfaction and retention.
• **Creditors**: The company's history of losses and substantial doubt about its going concern ability increase the risk for creditors, although the July Notes have been fully repaid.
• **Management**: Faces pressure to improve financial performance, regain Nasdaq compliance, and secure additional funding to ensure the company's viability.

Next Steps

• Regain compliance with Nasdaq's minimum bid price rule by April 6, 2026, potentially through a reverse stock split.
• Increase revenues to achieve profitability and positive cash flows.
• Secure additional capital to fund future expansion plans, which may involve public or private equity offerings or debt financing.
• Expand and optimize the sales infrastructure to grow the customer base.
• Address material weaknesses in internal controls related to segregation of duties.
• Monitor and manage the impact of potential dilution from warrant exercises and future capital raises.
• Continue to develop and market new products to increase sales to existing and new customers.

Key Dates

Recommendation

The filing reveals a company in severe financial distress, marked by persistent losses, declining revenue, and explicit 'substantial doubt about our ability to continue as a going concern' from its auditors. The Nasdaq delisting threat, with a compliance deadline of April 6, 2026, adds significant uncertainty and risk to the stock's liquidity and valuation. The large volume of shares registered for resale by selling stockholders, coupled with potential future dilution from warrant exercises and necessary capital raises, will likely exert downward pressure on the share price. For a seasoned investor, these factors collectively point to a high probability of further capital erosion and warrant a strong sell recommendation.

Keywords

SCWorx Corp, WORX, S-1 Registration, Equity Incentive Plan, Common Stock, Warrants, Dilution, Nasdaq Delisting, Going Concern, Healthcare IT, Data Normalization, Interoperability, Big Data Analytics, SaaS, Financial Losses, Capital Raise, Risk Factors, SEC Filing